Arkolith/Insider Trading/LCTX/Form 4

Hogge Gary S.

SVP,Clinical & Medical AffairsLineage Cell Therapeutics, Inc. (LCTX) · full profile →Form 4 · filed Feb 14, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2023Option exercise(M)13K——13K
Feb 11, 2023Tax withholding(F)5K$1.35$7K8K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 11, 2023Option exercise(M)13K—$039K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-004895) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML